$872.68
-1.02-0.12%
Last update: Oct 26, 11:14 AM
argenx SE (ARGX) Stock Price, Quote, News & History
ARGXNASDAQ
Argenx announced Phase 2 success for FB102 in celiac disease while halting its Phase 3 UNITY study in Sjögren's disease for futility.
You can purchase shares of argenx (NASDAQ:ARGX) through any online brokerage.
Other companies in argenx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
argenx has a consensus price target of $1103.50.
The stock price for argenx (NASDAQ: ARGX) is $872.685 last updated October 26, 2026 at 11:14 AM EDT.
There are no upcoming dividends for argenx.
argenx does not have any upcoming earnings scheduled.
There is no upcoming split for argenx.
argenx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized...
